Skip to content

Acceptance of Complementary Medicine in Germany

Acceptance of Complementary Medicine in Germany - an Anonymous Representative Cross-sectional Study Including a Qualitative Survey

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05530720
Enrollment
4505
Registered
2022-09-07
Start date
2022-09-19
Completion date
2022-10-17
Last updated
2024-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Population

Brief summary

Complementary medicine is widely practiced in Germany and worldwide. The aim of this study is to explore how many people use complementary medicine methods in Germany, for which health-related issues they do and for which they would not.

Interventions

No intervention.

Sponsors

Otto-Friedrich-University Bamberg, Chair of Sociology, Prof. Dr. Rasmus Hoffmann
CollaboratorUNKNOWN
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 110 Years
Healthy volunteers
Yes

Inclusion criteria

* Informed consent * Age at least 18 years * Sufficient language skills as well as cognitive ability to participate in an online survey or interview lasting approximately 30 minutes * Active consent to the online consent form

Exclusion criteria

\- Lack of consent to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Assessment of attitudes towards complementary medicineUp to 24 weeksAssessed retrospectively with self-designed questions

Secondary

MeasureTime frameDescription
Sociodemographic ParametersUp to 24 weeksAssessed retrospectively with self-designed questions
Assessment of knowledge of complementary medicineUp to 24 weeksAssessed retrospectively with self-designed questions
Assessment of own application of complementary medicineUp to 24 weeksAssessed retrospectively with self-designed questions
Assessment of attitudinal and behavioral questions (e.g. lifestyle)Up to 24 weeksAssessed retrospectively with self-designed questions
Assessment of use of complementary medicine in the Covid-19 pandemicUp to 24 weeksAssessed retrospectively with self-designed questions
Assessment of medical history and quality of life by EQ-5D-5LUp to 24 weeksAssessed retrospectively with self-designed questions

Other

MeasureTime frame
Qualitative interviews of expertsConducted after completion of the questionnaire (once), up to 24 weeks
Qualitative interviews of participantsConducted after completion of the questionnaire (once), up to 24 weeks

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026